http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2212418-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_044717e180537adab739d242a46f84b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcb8688636431bbf06cf69df9289e2fa |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1388 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-137 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 |
| filingDate | 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_322e28790ec917eb628de5f6f38d1eb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ae4e709e1f5d820f32f8e6b3b2b687 |
| publicationDate | 2010-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2212418-A1 |
| titleOfInvention | Methods for co-culturing cord blood derived cells with menstrual stem cells |
| abstract | Methods are provided for obtaining expanded human cord blood cells expressing CD34. The methods involve seeding a sufficient amount of cord blood cells with a sufficient amount of menstrual cells under co-culture conditions suitable to promote expansion of the cord blood cells, and co-culturing the cord blood cells with the menstrual cells under culture conditions that support at least two or more population doublings of the cord blood cells. Methods are also provided for growing expanded human cord blood cells to give rise to any one of colony forming units, colony forming unit granulocyte macrophages (CFU-GM), burst forming unit erythroids (BFU-E), and colony forming unit granulocyte erythrocyte macrophage megakaryocyte (CFU- GEMM) blood lineage precursor cells. The expanded cells may express CD34, SSEA-4, and HLA-II. Compositions of the expanded cells are also provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011101054-A1 |
| priorityDate | 2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 366.